pyrazines has been researched along with Brain Vascular Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hebbel, RP; Hedlund, BE | 1 |
| Fu, Y; Liu, X; Sun, H; Zhao, T | 1 |
| Chen, KJ; Guo, SK; Qian, MY; Qian, ZH; Weng, WL | 1 |
| Phillis, JW | 1 |
| Chen, K; Chen, KJ | 1 |
| Gao, BT | 1 |
| Ho, WK; Lee, CM; Wen, HL | 1 |
1 review(s) available for pyrazines and Brain Vascular Disorders
| Article | Year |
|---|---|
Ischemic stroke treated with Ligusticum chuanxiong.
Topics: Animals; Cerebrovascular Disorders; Coumaric Acids; Drugs, Chinese Herbal; Humans; Platelet Aggregation Inhibitors; Pyrazines | 1992 |
6 other study(ies) available for pyrazines and Brain Vascular Disorders
| Article | Year |
|---|---|
Sickle hemoglobin oxygen affinity-shifting strategies have unequal cerebrovascular risks.
Topics: 2,3-Diphosphoglycerate; Anemia, Sickle Cell; Benzaldehydes; Cerebrovascular Circulation; Cerebrovascular Disorders; Erythrocytes, Abnormal; Hematocrit; Hematologic Agents; Hemoglobin, Sickle; Hemolysis; Humans; Hypoxia; Microcirculation; Models, Biological; Organ Specificity; Oxygen; Oxyhemoglobins; Polymerization; Protein Binding; Pyrazines; Pyrazoles; Risk Assessment | 2018 |
Ligustrazine suppresses neuron apoptosis via the Bax/Bcl-2 and caspase-3 pathway in PC12 cells and in rats with vascular dementia.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain-Derived Neurotrophic Factor; Carotid Artery, Common; Caspase 3; Cell Hypoxia; Cell Survival; Cerebrovascular Disorders; Chemokine CCL2; Dementia, Vascular; Gene Expression Regulation; Glucose; Homocysteine; Ligusticum; Male; Mitochondria; Neurons; Neuroprotective Agents; PC12 Cells; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Rats; Rats, Wistar; Signal Transduction | 2018 |
Tetramethylpyrazine in the treatment of cardiovascular and cerebrovascular diseases.
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Humans; Medicine, Chinese Traditional; Pyrazines | 1983 |
The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.
Topics: Animals; Behavior, Animal; Caffeine; Carotid Arteries; Cerebral Cortex; Cerebrovascular Disorders; Dimethyl Sulfoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Gerbillinae; Locomotion; Male; Purinergic P1 Receptor Antagonists; Pyrazines; Reperfusion Injury; Xanthines | 1995 |
[The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke].
Topics: Aged; Aged, 80 and over; Aspirin; Betahistine; Cerebrovascular Disorders; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Pyridines; Vasodilator Agents | 1989 |
Tetramethylpyrazine for treatment of experimentally induced stroke in Mongolian gerbils.
Topics: Animals; Binding, Competitive; Brain; Brain Ischemia; Cerebrovascular Disorders; Gerbillinae; Male; Pyrazines | 1989 |